3 hours away⬇️ #webinar #medicaldevice #hairloss #therapy #dermtwitter #dermatology #aesthetics

Let's go @HairDAO!

Kintor Pharmaceutical has announced an additional long-term safety phase 3 trial for #pyrilutamide aka #KX826 in China. This likely means that the timeline to approval has been increased significantly. ➡️folliclethought.com/kintor-seeks-p… #Kintor #AGA #dermtwitter #femaleAGA

Allogeneic "Off the shelf" PRP for hair growth may be a treatment option in the coming years. One company is already embarking on a therapeutic program. #PRP #aesthetics #dermtwitter #hairgrowth #aga #alopecia $CTCX ➡️folliclethought.com/allogeneic-off…

Although there are some bad things in the world, remember that there are many good things too

I've been hearing a lot about the Longevity Summit Dublin Conference, I bet many of the enthusiasts there would be interested to hear of the hair growth treatments in clinical trials this year.➡️folliclethought.com/alopecia-clini…⬅️#aesthetics #Longevitysummitdublin #longevitysummit #hairregrowth

Kintor Pharmaceutical's GT20029 #androgen receptor degrader drug has completed patient enrollment in a Phase 2 clinical trial for male AGA in China. Read here for more details ➡️folliclethought.com/kintor-announc… #clinicaltrial #mAGA #AGA #kintor #GT20029

A very important trial in the world of #androgenicalopecia is still set to begin by the end of the year, according to Epibiotech's CEO. Read more ➡️folliclethought.com/epibiotech-epi… #Celltherapy #AGA #Epibiotech #dermatology #biotech

Partners Q32 Bio Inc. and Horizon recently announced the first patient dosed in a phase 2 trial of antibody bempikibart for the treatment of severe adult alopecia areata. This is currently Horizon's second program in AA. ➡️folliclethought.com/updates/alopec…⬅️ #dermtwitter #alopeciaareata

Junji Fukuda's company TrichoSeeds Co. will be competing against other biotech innovations at the 5th Healthcare Venture Awards in Japan on October 27th. More about the #haircloning startup here ➡️folliclethought.com/fukuda-lab-tri…⬅️#TrichoSeedsCo #biotech #antiaging

Dr. Bloxham of Feller & Bloxham Medical shares his insights from the first few months of a study he is conducting on verteporfin in FUT wound healing. #verteporfin #FUT #hairtransplant #woundhealing ➡️folliclethought.com/verteporfin-ha…

📰Triple Hair has raised funds through an overseas licensing deal for its candidate TH-07. The development appears to be an important step towards the initiation of an upcoming phase 3 clinical trial. More at folliclethought.com/updates/⬅️#triplehair #aesthetics #medicine #th07

Exclusive interview with the CEO of OrganTech (Dr. Tsuji's Co) about their plans to enter a human hair cloning trial in 2024, published yesterday.➡️folliclethought.com/organtech-hair…⬅️ #haircloning #hairtransplant #OrganTech #Japan #Tsuji #IPOAlert

Hope Medicine's monoclonal antibody therapy HMI-115 has begun a phase 2 trial for androgenic alopecia in China. 👀➡️folliclethought.com/hmi-115-begins…⬅️#monoclonalantibody #HMI115 #dermtwitter #retweetthis #hairgrowth #drug

A new oral medication which does not affect hormones is being trialed against pattern #hairloss. According to Veradermics, the drug represents an important potential treatment against AGA in both men and women. #dermtwitter #veradermics #spreadthenews ➡️folliclethought.com/updates/verade…

The world's most recent furthest developed (Phase 3) drug for AGA, KX-826 aka pyrilutamide by Kintor Pharmaceutical, has issued an important data announcement regarding efficacy. Spoiler alert is the results are not what we hoped for. #kx826 More here➡️folliclethought.com/updates/kintor…

A reader of mine had a great idea for the use of #verteporfin for hair restoration in the comments of my latest article. The post also includes a timeline update from Stemson Therapeutics, a leading company in the hair cloning circuit. #haircloning #hairregrowth ➡️folliclethought.com/hair-cloning-r…